Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 0161-5505
Author Salaun, Pierre-Yves, Campion, Loïc, Bournaud, Claire, Faivre-Chauvet, Alain, Vuillez, Jean-Philippe, Taieb, David, Ansquer, Catherine, Rousseau, Caroline, Borson-Chazot, Françoise, Bardet, Stéphane, Oudoux, Aurore, Cariou, Bertrand, Mirallié, Eric, Chang, Chien-Hsing, Sharkey, Robert M, Goldenberg, David M, Chatal, Jean-François, Barbet, Jacques, Kraeber-Bodéré, Françoise
Maintainer CCSD
Last Updated May 7, 2026, 09:19 (UTC)
Created May 7, 2026, 09:19 (UTC)
Identifier hal-00932253
Language en
contributor Department of Nuclear Medicine ; Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)
creator Salaun, Pierre-Yves
date 2012-08-07T00:00:00
harvest_object_id abf55230-d7b9-4dcc-b6c9-7febe0b85afd
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-04-27T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.2967/jnumed.111.101865
set_spec type:ART